Oncogenes associated with drug resistance in ovarian cancer

作者: Xia Liu , Yutao Gao , Yi Lu , Jian Zhang , Li Li

DOI: 10.1007/S00432-014-1765-5

关键词:

摘要: Oncogenes play pivotal roles in the development of cancer, and disturbances their expression have been implicated drug resistance. However, an overview contribution oncogenes to resistance ovarian cancer has not previously reported. This study aimed review resistance-related precisely determine relationships. The associated with from available papers were summarized, a comprehensive bioinformatics analysis including pathway enrichment, biological processes annotation, protein/gene interaction microRNA–mRNA was performed. Total 25 contributing integrated further analyzed. An oncogene-mediated that explains associations 21 these drafted on basis published papers. downstream location v-akt murine thymoma viral oncogene (AKT) B-cell CLL/lymphoma 2-associated X protein (BAX) respect many other determined, indicating two genes may central role, AKT- BAX-mediated signaling are main pathways accounting for involvement cancer. Besides, annotation process indicated apoptosis (cell death) phosphorylation (phosphate metabolic process) might be major routes through which contribute In addition, interactions, 11 microRNAs identified targeted at least 7 oncogenes, those could important regulator oncogenes. Collectively, by integrating analyzing data this contributes improving our understanding mechanisms leads

参考文章(141)
Li Wei, Tao Xue, Jian Wang, Biliang Chen, Yingfeng Lei, Yanhong Huang, Hongying Wang, Xiaoyan Xin, Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer. International Journal of Cancer. ,vol. 125, pp. 791- 806 ,(2009) , 10.1002/IJC.24316
Stefanie Fister, Andreas R. Günthert, Babette Aicher, Klaus W. Paulini, Günter Emons, Carsten Gründker, GnRH-II Antagonists Induce Apoptosis in Human Endometrial, Ovarian, and Breast Cancer Cells via Activation of Stress-Induced MAPKs p38 and JNK and Proapoptotic Protein Bax Cancer Research. ,vol. 69, pp. 6473- 6481 ,(2009) , 10.1158/0008-5472.CAN-08-4657
Jean-Philippe Theurillat, Stefan Christian Metzler, Nico Henzi, Nabil Djouder, Marianne Helbling, Anna-Kathrin Zimmermann, Francis Jacob, Alex Soltermann, Rosmarie Caduff, Viola Heinzelmann-Schwarz, Holger Moch, Wilhelm Krek, URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell. ,vol. 19, pp. 317- 332 ,(2011) , 10.1016/J.CCR.2011.01.019
S. Srikantan, K. Abdelmohsen, E. K. Lee, K. Tominaga, S. S. Subaran, Y. Kuwano, R. Kulshrestha, R. Panchakshari, H. H. Kim, X. Yang, J. L. Martindale, B. S. Marasa, M. M. Kim, R. P. Wersto, F. E. Indig, D. Chowdhury, M. Gorospe, Translational Control of TOP2A Influences Doxorubicin Efficacy Molecular and Cellular Biology. ,vol. 31, pp. 3790- 3801 ,(2011) , 10.1128/MCB.05639-11
Hui Xing, Danhui Weng, Gang Chen, Wenming Tao, Tao Zhu, Xiaokui Yang, Li Meng, Shixuan Wang, Yunping Lu, Ding Ma, Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells. Cancer Letters. ,vol. 261, pp. 108- 119 ,(2008) , 10.1016/J.CANLET.2007.11.022
Jane Warwick, Lawrence S. Young, Gerald Niedobitek, Aristides G. Eliopoulos, David J. Kerr, J. Jonathan O. Herod, The Prognostic Significance of Bcl-2 and p53 Expression in Ovarian Carcinoma Cancer Research. ,vol. 56, pp. 2178- 2184 ,(1996)
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal, Cancer statistics, 2013 CA: A Cancer Journal for Clinicians. ,vol. 63, pp. 11- 30 ,(2013) , 10.3322/CAAC.21166
Rebecca Siegal, KD Miller, Ahmddin Jemal, Cancer statistics, 2012 CA: A Cancer Journal for Clinicians. ,vol. 62, pp. 10- 29 ,(2012) , 10.3322/CAAC.20138